October 19, 2026
Business

HAB Pharma targets ₹3,000 crore revenue by 2030 after merger deal(Soban News)

HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal

​HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal by Soban News (international And National News)

Related posts

Can Prasol Chemicals IPO deliver long-term growth for high-risk investors?(Soban News)

News-Soban-Admin

An End Of An Era In Indian Tennis! Rohan Bopanna Hangs Up Racquet After Two Decades – News18(Soban News)

News-Soban-Admin

Macho reels, dancers & ‘Yadav pride’—social media profile of key accused in Bihar groping case – ThePrint(Soban News)

News-Soban-Admin

Leave a Comment